| Literature DB >> 36217147 |
Isabel C Olegário1,2, Bruna L P Moro2, Tamara K Tedesco3, Raiza D Freitas2, Ana Laura Pássaro2, Jonathan Rafael Garbim2, Rodolfo Oliveira2, Fausto M Mendes2, Daniela Prócida Raggio4,5.
Abstract
BACKGROUND: This non-inferiority randomised clinical trial aimed to evaluate the survival of direct bulk fill composite resin restorations in primary molars using different methods of moisture control: rubber dam isolation (RDI-local anaesthesia and rubber dam) and cotton roll isolation (CRI-cotton roll and saliva ejector). Secondary outcomes included baseline and 2-year incremental cost, self-reported child's pain scores and patient behaviour during the restorative procedure.Entities:
Keywords: Children; Composite resin; Non-inferiority; Primary teeth; Randomised clinical trial; Rubber dam
Mesh:
Substances:
Year: 2022 PMID: 36217147 PMCID: PMC9552420 DOI: 10.1186/s12903-022-02449-y
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 3.747
Fig. 1CONSORT Flow Diagram
Baseline characteristics between study groups and restoration drop-out after 24-months
| RDI | CRI | Stayed in | 24-month | |
|---|---|---|---|---|
Total N (%) | 86 (49.43) | 88 (50.57) | 157 (90.23) | 17 (9.77)* |
| Categorical variables—N (%) | ||||
| Sex | ||||
| Female | 33 (49.25) | 34 (50.75) | 61 (91.04) | 6 (8.96) |
| Male | 53 (49.53) | 54 (50.47) | 96 (89.72) | 11 (10.28) |
| Number of Surfaces | ||||
| Single surface (1) | 23 (52.27) | 21 (47.73) | 38 (86.36) | 6 (13.64) |
| Multisurface (> 1) | 63 (48.46) | 67 (51.54) | 119 (91.54) | 11 (8.46) |
| Molar | ||||
| First Molar | 46 (50.00) | 46 (50.00) | 82 (89.13) | 10 (10.87) |
| Second Molar | 40 (48.78) | 42 (51.22) | 75 (91.46) | 7 (8.54) |
| Operator | ||||
| Specialist | 50 (52.63) | 45 (47.37) | 84 (88.42) | 11 (11.58) |
| GDP | 36 (45.57) | 43 (54.43) | 73 (92.41) | 6 (7.59) |
| Restoration type | ||||
| New restoration | 56 (50.45) | 55 (49.55) | 98 (88.29) | 13 (11.71) |
| Restoration replacement | 30 (47.62) | 33 (52.38) | 59 (93.65) | 4 (6.35) |
| Continuous variable—mean (SD) | ||||
| DMFT/dmft | 6.94 (3.62) | 7.98 (3.73) | 7.68 (3.42) | 5.52 (5.44) |
| Number of surfaces | 2.09 (1.02) | 2.22 (1.05) | 2.15 (1.01) | 2.23 (1.34) |
*9 children who dropped-out were from RDI group and 8 were from the CRI group (p = 0.760, by chi-square test)
Fig. 2Kaplan–Meier Survival analysis between groups (log rank = 0.245)
Primary outcome analysis (restoration survival) using non-inferiority Cox Regression and Intention-to-treat analyses
| Outcomes | RDI | CRI | |
|---|---|---|---|
| Primary outcome—Non-Inferiority Cox Regression analysis* | |||
| % Survival | 60.41% | 54.31% | 0.036 |
| HR (90% C.L. of HR) | 1.33 (0.88–1.99) | ||
| Primary outcome—Intention-to-treat analysis (2 years) ** | |||
| N success/N total | 54/86 | 51/88 | 0.003 |
| % Success | 62.79% | 57.95% | |
| Absolute difference (95%CI) | 0.05 (− 0.09 to 0.19) | ||
| OR (95%CI) ** | 1.22 (0.67–2.25) | 0.201 | |
HR = Hazard Ratio; OR = Odds ratio
Ha = non-inferiority at α = 5%
* 100(1−2α)% Confidence Interval and p-value for non-inferiority survival data (Wald test)
** p values and 95% CI were derived by Miettinen and Nurminen’s method using non-inferiority test for two proportions
Fig. 3Possible results of a non-inferiority clinical trial considering a non-inferiority limit of 15% between groups using survival results as primary outcome (HR = 0.85)
Univariate and adjusted two-tailed Cox Regression Analysis between restorative treatment failure and prognostic factors
| Variable | Survival rate % | 95% CI | HR Univariate | HR Adjusted 95% CI | Two-tailed p-value | |
|---|---|---|---|---|---|---|
| Group | ||||||
| RDI (ref) | 60.41 | 48.40–70.47 | 1.36 (0.82–2.23) | 0.222 | 1.34 (0.81–2.19) | 0.244 |
| CRI | 54.31 | 42.52–64.67 | ||||
| Restoration | ||||||
| New restoration (ref) | 63.16 | 52.83–71.83 | 1.54 (0.95–2.52) | 0.079 | 1.53 (0.93–2.52) | 0.093 |
| Replacement | 46.43 | 32.60–59.16 | ||||
| Number of Surfaces | ||||||
| Single (ref) | 62.65 | 45.69–75.64 | 1.18 (0.66–2.11) | 0.565 | 1.08 (0.60–1.95) | 0.782 |
| Multiple | 55.43 | 45.74–64.08 | ||||
| Molar | ||||||
| 1st molar (ref) | 52.95 | 41.36–63.25 | 0.72 (0.44–1.18) | 0.203 | – | – |
| 2nd molar | 62.00 | 49.79–77.05 | ||||
| Caries experience (DMFT/dmft) | ||||||
| Low (1–3) (ref) | 52.38 | 26.54–72.97 | 1.02 (0.48–2.16) | 0.956 | – | – |
| High (> 3) | 57.67 | 48.86–65.51 | ||||
| Operator | ||||||
| Specialist (ref) | 56.70 | 45.27–66.61 | 1.04 (0.63–1.69) | 0.872 | – | – |
| GDP | 58.20 | 45.75–68.75 | ||||
| TOTAL | 57.30 | 49.01–64.74 | ||||
HR = Hazard ratio; CI = Confidence Interval; SE = Standard Error p < 0.05–95% CI
Adjusted analysis considered only study group, type of restoration and number of surfaces
Fig. 4Distribution between mean professional and material baseline cost between study groups in US$
Evaluation of the baseline and 2-year incremental cost between groups and number of surfaces over time using Bootstrap regression analysis (1000 repeats) using Linear Regression considering the child level
| Cost analysis | Mean | Univariate analysis | Adjusted analysis | ||
|---|---|---|---|---|---|
| Coefficient (SE) | Coefficient (SE) | ||||
| Baseline Total Cost | |||||
| Study Groups | |||||
| RDI (ref) | 17.65 (6.62) | − 6.88 (0.89) | < 0.001* | − 6.95 (0.93) | < 0.001* |
| CRI | 10.76 (5.09) | − 8.64 to − 5.12 | − 8.79 to − 5.11 | ||
| Number of surfaces | |||||
| Single (ref) | 12.65 (5.97) | 2.01 (1.04) | 0.053 | 2.28 (0.76) | 0.003* |
| Multiple | 14.67 (7.03) | -0.02 to 4.06 | 0.77–3.78 | ||
| 2 years Total Cost | |||||
| Study Groups | |||||
| RDI (ref) | 24.62 (19.42) | − 8.51 (2.44) | < 0.001* | -8.69 (2.45) | < 0.001* |
| CRI | 16.11 (10.64) | − 13.30 (− 3.72) | − 13.49 to − 3.88 | ||
| Number of surfaces | |||||
| Single (ref) | 15.95 (7.25) | 5.83 (1.89) | 0.002* | 6.16 (1.94) | 0.001* |
| Multiple | 21.79 (17.98) | 2.11–9.56 | 2.36 to 9.97 | ||
CI = Confidence interval; SE = Bootstrap Standard error; SD = standard deviation; *p < 0.05
All costs were measured in Brazilian reais (R$) and converted to US Dollars (US$) using purchasing power parities (PPP)– Conversion rate 1US$ = 2.311R$
Fig. 5Cost-effectiveness of using CRI versus RDI considering costs (US$) and effectiveness (survival in months)
Fig. 6Distribution between pain reported by the child after treatment between groups
Fig. 7Distribution between child behaviour (Frankl's behaviour rating scale—FBRS) reported by the operator after treatment between groups